← Leaderboards
Matthew Seavey
Pelican Therapeutics, Inc.
$524,124
Attributed
$524,124
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.4K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$524,124 · 2
By mechanism
R43$299,411 · 1
R41$224,713 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Receptor”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Jay Evans · University Of Montana$23,751,494
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$22,797,910
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Andrew S Huhn · Johns Hopkins University$17,444,676
Research focus
ReceptorEnzyme-Linked Immunosorbent AssayIn VivoProductionMonitorImmuneDoseIn VitroMediatingMouse ModelSpleenMortalityLiverKineticsBloodDiagnosisAntigensAntidotesAffinityAntibodiesBiological SciencesAnimalsAerosolsAdherence